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Review
Killers creating new life: caspases drive apoptosis-
induced proliferation in tissue repair and disease
Caitlin E Fogarty1 and Andreas Bergmann*,1
Apoptosis is a carefully orchestrated and tightly controlled form of cell death, conserved across metazoans. As the executioners of
apoptotic cell death, cysteine-dependent aspartate-directed proteases (caspases) are critical drivers of this cellular disassembly. Early
studies of genetically programmed cell death demonstrated that the selective activation of caspases induces apoptosis and the precise
elimination of excess cells, thereby sculpting structures and refining tissues. However, over the past decade there has been a
fundamental shift in our understanding of the roles of caspases during cell death—a shift precipitated by the revelation that apoptotic
cells actively engage with their surrounding environment throughout the death process, and caspases can trigger a myriad of signals,
some of which drive concurrent cell proliferation regenerating damaged structures and building up lost tissues. This caspase-driven
compensatory proliferation is referred to as apoptosis-induced proliferation (AiP). Diverse mechanisms of AiP have been found across
species, ranging from planaria to mammals. In this review, we summarize the current knowledge of AiP and we highlight recent
advances in the field including the involvement of reactive oxygen species and macrophage-like immune cells in one form of AiP, novel
regulatorymechanisms affecting caspases during AiP, and emerging clinical data demonstrating the critical importance of AiP in cancer.
Cell Death and Differentiation (2017) 24, 1390–1400; doi:10.1038/cdd.2017.47; published online 31 March 2017
Facts
 Activated caspases trigger a form of compensatory
proliferation, referred to as apoptosis-induced proliferation
(AiP), through secretion of mitogens.
 AiP is best characterized in epithelial cells, and is critical for
epithelial wound repair and regeneration across species.
 There are several context- and tissue-specific forms of AiP
currently characterized.
 The initiator caspase-dependent AiP mechanism involves
JNK signaling, reactive oxygen species (ROS) and recruit-
ment of macrophage-like immune cells.
 Sustained AiP causes tissue overgrowth, and may con-
tribute to tumor growth and treatment resistance.
Open Questions
 Why does activation of caspases in apoptosis sometimes
induce AiP and other times not? Conversely, how might
caspases be controlled to at times induce only AiP in the
absence of cell death?
 Are cell types other than epithelial cells subject to AiP?
 What are the direct targets of caspases in AiP? Are all
targets cleaved?
 Howgeneral is the involvement of AiP in tumor development?
 Does AiP contribute to other disease processes?
Death-dependent proliferation
Most, if not all, animals have some capacity to regenerate lost
tissue, but there is great variability in that capacity, dependent
on the species and developmental context. Some forms of
regeneration depend on compensatory proliferation, a pro-
cess bywhich the volume of damaged or lost tissue is replaced
via additional mitotic divisions within the healthy neighboring
tissue (Figure 1a). The first quantitative evidence for compen-
satory proliferation came from studies in Drosophila melano-
gaster. In 1977, it was demonstrated that irradiated wing
precursor tissue (imaginal discs) of the developing fly larva,
despite elimination of up to 60% of cells, could yield a normal
sized wing with appropriate patterning due to subsequent
increase in mitosis among surviving cells.1 Follow-up studies
found that the increased mitosis following apoptosis could
consistently and appropriately accommodate for the lost
tissue, suggesting the two processes were directly linked.2,3
Several studies in 2004 supported the concept of apoptosis-
dependent proliferation. In planarians, caspase-like genes are
activated, and apoptotic cells are present throughout the
regenerative process, well beyond the original injury.4 In
newts, apoptosis was found to be required for proper limb
regeneration.5 Multiple studies in Drosophila found that
induction of the apoptotic machinery was sufficient to promote
non-autonomous proliferation in the surrounding cells, inde-
pendent of completed cell death.6–8 These and follow-up
studies established that the Drosophila initiator caspase
Dronc was specifically responsible for driving compensatory
proliferation following initiation of apoptosis.6,9,10
Apoptosis-induced proliferation (AiP) is the designated term
for the distinct subtype of compensatory proliferation specifi-
cally triggered by the apoptotic machinery.11 AiP is not a single
pathway, but encompasses a variety of signaling cascades by
1Department of Molecular, Cell and Cancer Biology, University of Massachusetts Medical School, 364 Plantation Street, LRB 419, Worcester, MA 01605, USA
*Corresponding author: A Bergmann, Molecular, Cell and Cancer Biology, University of Massachusetts Medical School, 364 Plantation Street, LRB 419, Worcester,
MA 01605, USA. Tel: +1 508 856 6023; Fax: +1 508 856 1310; E-mail: Andreas.bergmann@umassmed.edu
Received 23.1.17; revised 26.2.17; accepted 28.2.17; Edited by E Arama; published online 31.3.17
Cell Death and Differentiation (2017) 24, 1390–1400
Ofﬁcial journal of the Cell Death Differentiation Association
www.nature.com/cdd
which caspases promote non-autonomous proliferation
through secretion of mitogens, often in parallel to, but
independent of the final execution of apoptotic cell
death.12–18 These caspase-dependent signaling path-
ways play a critical role in wound healing and regeneration
(Figure 1a and b). Furthermore, apoptotic caspases may also
contribute to tumor initiation, caspase-dependent inflamma-
tion, and sustained AiP in tumor initiation. Tumors have been
Figure 1 The Spectrum of AiP in wound healing, regeneration, and the development of cancer. On the left, shown are sheets of epithelial cells. On the right, the relative timing
of caspase activity, AiP and the recruitment of immune cells as well as cancer cells (c) is illustrated. Based on the variety of caspase-dependent AiP mechanisms, it is clear that
the phenomenon of AiP includes a spectrum of functions from simple transient wound healing, to more complex regeneration, to responding to chronic damage and inflammation.
(a) Transient AiP is a self-limited proliferation in direct response to caspase activation in some apoptotic cells. (b) AiP associated with more significant or sustained wound healing
often requires additional support including from the immune cells recruited by caspase-dependent signals such as extracellular ROS, but eventually resolves upon tissue repair.
(c) Caspase-dependent AiP which occurs during ongoing or repeated damage, such as in chronic inflammatory diseases, can lead to an imbalance in cell death versus
proliferation, leading to tissue dysplasia, hyperplasia, or possible neoplasia from the AiP stimulation of damaged cells containing new cancer-causing mutations
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described as analogous to wounds that don’t heal,19 and
chronic inflammatory states, often characterized by repeated
cycles of cell death and incomplete wound healing, are
known to predispose to the development of certain cancers
(Figure 1c).20 Here, we will explore the mechanisms, regula-
tion, and significance of caspase-driven AiP.
The many mechanisms of caspase-driven AiP
The mitochondrial apoptosis pathway is well conserved
among species. The major players include: (1) the death
proteases—initiator and effector caspases, synthesized as
inactive zymogens and activated through multimerization and
proteolytic cleavage. Seven caspases in humans are involved
in control of apoptosis, of which caspase-2,-8,-9 and -10
function as initiators of apoptosis, while caspase-3,-6 and -7
are the effectors of apoptosis.21 Drosophila have three
caspases known to be involved in apoptosis: the initiator
caspase Dronc (homolog of caspase-2,-9) and the effector
caspases DrICE and Dcp-1 (homologs of caspase-3,-7).22 (2)
Apaf-1/Dark, scaffolding proteins that complex with the
initiator caspase (caspase-9/Dronc) to form the active
apoptosome. (3) Multiple upstream pro-apoptotic and anti-
apoptotic factors whose opposing actions control where and
when initiation of apoptosis occurs.22–24 In mammals, Bcl-2
family proteins regulate activation via the mitochondria,25
whereas in flies, the pro-apoptotic genes reaper, hid and
grim activate apoptosis by antagonizing the E3-ligase Droso-
phila Inhibitor of Apoptosis Protein1 (DIAP1), a negative
regulator of caspase activation (Figure 2a).26–30 DIAP1 mono-
ubiquitylates the initiator caspase Dronc to inhibit its apoptotic
activity.31–36 These regulatorymechanisms affect both apoptosis
and caspase-driven AiP, but potentially to different
degrees.17,37,38
Inmammals, to date only the effector caspase-3 and -7 have
been shown to be involved in AiP.15,39–44 In Drosophila, Dronc
as well as DrICE and Dcp-1 have been implicated in distinct
forms of AiP.6,9,10,13,17,45,46 Here, we will discuss the roles of
caspases in AiP and their effects on downstream signaling
events in flies and mammals.
The Drosophila initiator caspase Dronc triggers a JNK-
dependent proliferative stress response. Most of the
foundational work characterizing caspase-dependent prolif-
eration has utilized genetic models of AiP in the Drosophila
imaginal discs, developing epithelial tissues with high
regenerative capacity.46,47 The ‘undead’ model, so called
as pro-apoptotic genes (such as reaper or hid) are over-
expressed while execution of cell death is blocked
by co-expressing the effector caspase inhibitor p35,48,49
allows for uncoupling of the functions of Dronc from the
effector caspases and the actual execution of apoptosis
(Figure 2b).6–9,17,50–52 This uncoupling was key to revealing
the role of activated Dronc as a necessary and sufficient
driver of mitogen production and AiP in developing epithelial
tissues. Dronc-mediated AiP depends on activation of
JNK,8,17,53 and the production of mitogens such as the Wnt
homolog Wingless (Wg), the EGF homolog Spitz (Spi), the
interleukin-6 homolog Unpaired (Upd), and the BMP/TGFβ
homolog Decapentaplegic (Dpp) (Figure 2a and b).7,8,17,51,54
Interestingly, heterozygosity of dronc substantially sup-
pressed JNK-dependent AiP, but not apoptosis,9,10,17,53,55
suggesting that there is a higher caspase threshold for
activation of AiP as compared to apoptosis, when pro-
apoptotic stimuli are present.
Figure 2 Mechanisms of caspase-dependent AiP. Apoptosis-induced prolifera-
tion may be induced by either initiator (a and b) or effector (c–e) caspases. Activation
of these caspases under certain conditions results in a variety of signaling cascades,
producing a variety of growth factors and other mitogenic signals. (a and b) The
Drosophila caspase Dronc is the only initiator caspase to date characterized as
independently driving AiP. In transient regeneration (a), the active apoptosome
including Dronc, triggers production of extracellular ROS and activates JNK, leading
to production of the secreted mitogens Wingless (Wg) and Spitz (Spi). More
sustained regeneration (b) requires additional input from recruited immune cells,
signaling through the TNF homolog Eiger (Egr) and its receptor Grindelwald (Grnd),
and possibly involves additional mitogens. (c–e) Effector caspases are implicated in
AiP across the species, but examples shown here have confirmed the requirement of
effector caspase activity. (c) In hydra, regeneration of an amputated head is
dependent on caspase activity in the apoptotic cells at the regeneration site. These
cells release the mitogen Wnt3. (d) The effector caspases Drice and DCP-1 are
required for Hedgehog (Hh) production in Drosophila during AiP in maturing eye
tissues. (e) In mice and human cell lines, following any number of injuries, including
surgical resection, radiation or cytotoxic chemotherapies, caspase-3 cleaves a
phospholipase A2 (iPLA2) triggering production of prostaglandin E2 (PGE2) which
stimulates AiP. Caspase-3 also is required for VEGF-A production. Caspase-7
activates the kinase PKCδ, activating similar stress response pathways as seen in
Drosophila
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Upstream of JNK, a number of kinases and adaptor proteins
contribute to the context-dependent initiation of JNK
activity.56,57 Selective activation of subsets of these upstream
factors directs whether JNK activity is pro-apoptotic or pro-
survival.58 Howactivation of the same JNK (flies only have one
JNK homolog) by distinct upstream factors can trigger different
outcomes as diverse as death or survival remains largely
enigmatic. In undead models, only dTraf2 (JNKKKK), dTAK1
(JNKKK), and both Hep and dMKK4 (JNKKs) are required
upstream of JNK to drive AiP.17 However, despite the
identification of upstream JNK pathway components, how
Dronc activates JNK during AiP was less clear—until recently.
Dronc-dependent recruitment of immune cells promotes
JNK activation and enhances AiP through a positive
feedback amplification loop. A prominent feature of wound
healing and regeneration is the infiltration of immune cells to
the site of injury, which likely contributes to efficient healing
under typical conditions (Figure 1b), but they are not
fundamentally required for effective regeneration. For exam-
ple, mice lacking inflammatory cell lineages are still able to
repair of damage to their skin.59,60 However, we have
demonstrated recently that under certain circumstances
caspases can signal to immune cells to contribute to
sustained proliferation during AiP (Figure 2b). In epithelial
tissues, Dronc activation triggers the production of extra-
cellular reactive oxygen species (eROS) through the NADPH-
oxidase Duox.18 In many systems, eROS gradients are
known to recruit immune cells to sites of wound healing,61,62
and in the undead model, eROS are required to recruit
macrophage-like hemocytes to sites of apoptotic activity.18,63
Hemocytes in turn contribute to proliferation via amplification
of JNK-dependent signaling through production of the TNF
homolog Eiger (Figure 2b).18 Therefore, Dronc promotes JNK
activation through an inflammatory response that involves
eROS, hemocytes and TNF/Eiger signaling.
Effector caspases induce production of secreted mito-
gens from dying cells. Genetic screening using the undead
(p35-dependent) AiP model has provided a lot of intriguing
insight into the mechanisms of AiP, but excludes the
contributions of effector caspases, the enzymes most directly
associated with executing cell death, to AiP. Therefore,
several ‘genuine’ or regenerative (p35-independent) models
of AiP have been developed, in which tissues are first
subjected to a limited pro-apoptotic stimulus, and then they
are allowed to regenerate lost tissue through compensatory
AiP.17,18,64–67 These genuine/regenerative models have con-
firmed the requirement of JNK under physiological conditions,
and have been useful for investigating the spatiotemporal
dynamics of AiP.17,18,64–66
The genuine/regenerative AiP models have also shown that
effector caspases can promote proliferation through triggering
the production of diffusible mitogens. For example, in hydra,
caspase-3 activation in apoptotic cells promotes secretion of
Wnt3, a key signal for proliferation and remodeling, at the
site of head regeneration following mid-gastric bisection
(Figure 2c).14 In apoptotic photoreceptor neurons in Droso-
phila, DrICE and Dcp-1 drive the upregulation and secretion of
Hedgehog (Hh) which triggers activation of the Hippo growth
control pathway for AiP (Figure 2d).13,68 In mammalian
tissues, caspase-3 and -7 can cleave and activate the
calcium-insensitive phospholipase A2 (iPLA2), which in turn
produces several phospholipid signals involved in phago-
cyte migration, apoptotic cell detection and clearance, and
prostaglandin E2 (PGE2 ), a diffusible signal that promotes
stem and progenitor cell proliferation (Figure 2e).69–73
Caspase-3-dependent production of PGE2 is required for
epithelial wound healing in the skin of mice, contributes to liver
regeneration following partial hepatectomy, and has been
implicated in tumor growth and tumor repopulation following
targeted cytotoxic therapies.15,40 Caspase-7, while first linked
to activation of iPLA2, seems to be more important for
activation of protein kinase C delta (PKCδ), which in turn
mediates phosphorylation of Akt, p38 and JNK1/2 leading to
mitogen production and tumor repopulation following radiation
therapy (Figure 2e).42
Multiple mechanisms of AiP: redundancy or context-
specific? Controversies in the field of AiP are derived from
the differences between undead and genuine/regenerative
models. Depending on the model, the developmental stage,
or the tissue (eye versus wing imaginal discs), different
research groups conflict on the requirement and origins of
specific mitogens such as Wg and Dpp.47,51,64,66 Even in our
own recent work, we found that the role for hemocytes is not
conserved among all forms of AiP. It is clear that Dronc
triggers ROS production in response to pro-apoptotic stimuli
in both undead AiP and genuine/regenerative AiP models in
eye and wing discs.18,54 ROS is required for AiP in both
contexts (Figure 2a and b); however, immune cell recruitment
and TNF signaling does not appear to play a major role in the
context of the transient regenerative period in genuine
models, while it is clearly critical to the sustained proliferation
in the undead model (Figure 2a and b).18,54
These ‘discrepancies’ among the various models may in
fact reflect flexibility—different mechanisms of caspase-driven
AiP only activated under different contexts. There is already
evidence for differences based on developmental context in
flies—Dronc triggers AiP in undifferentiated eye tissue, but
with a few more hours of development, the effector caspases
DrICE and Dcp-1 become critical for driving AiP within the
more mature differentiated tissues.13 Alternatively, ‘discrepan-
cies’ could represent partial redundancy. Multiple AiP path-
ways may be activated sequentially or simultaneously
depending on the extent and duration of the insult. Ongoing
studies in Drosophila are taking advantage of the ever-
increasing genetic toolkit to systematically test these possibi-
lities. At the same time, there are opportunities in other model
systems to examine the conservation of these mechanisms,
probing for redundancy or variability. Although the function of
caspases in initiating a ROS-dependent proliferation pathway
is a new addition to the field of regeneration, the downstream
functions of ROS in redox signaling, damage detection, and
damage response have been the focus of many recent
studies.74 Notably, the mechanisms of ROS-dependent
proliferation—in recruitment of immune cells and in activa-
ting MAPK cascades—have been linked to wound healing
and regeneration in Hydra, Drosophila, Xenopus and
zebrafish.75,76 Hydrogen peroxide (H2O2) is a diffusible ROS
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molecule, which when initially produced from the site of injury
can form a chemoattractant gradient for leukocytes within the
first few hours following the trauma.61,62 This transient ROS
burst and the responding immune cells contribute to the
temporary healing of the wound site. In contrast, sustained
ROS production is required over the following 12–72 h for the
regeneration of complete structures (e.g., amputated tails of
Xenopus tadpoles).77,78While the initial transient burst of ROS
may simply be explained as nonspecific oxidative stress
released from the traumatized cells, the sustained ROS are
more likely actively produced by oxidases over this extended
time period. The sustained ROS signal in Xenopus activates
JNK and generates many of the known AiP-associated
mitogens (Wnt, TGFβ, BMP, etc), similar to the undead fly
model. These findings, taken together with the previously
reported requirement for Caspase-3 in Xenopus tail
regeneration,12 highlight one of many excellent opportunities
to look for conserved mechanisms of caspase-driven AiP,
connecting the dots between trauma, caspases, and eROS
signaling.
Intriguingly, Dronc is the only initiator caspase to date
conclusively shown to drive AiP independently of effector
caspases, while examples of effector caspase-driven AiP are
seen from hydra to humans. It is possible thatDrosophila has a
uniquely evolved mechanism of Dronc-dependent AiP; how-
ever, the parallels described above would suggest further
studies of caspase-2,-8 or -9-specific contributions to AiP in
other systems arewarranted. All future studies should be open
to the possibility of multiple paths from caspases to
proliferation.
The regulation of caspases in AiP: a matter of life or
death
While the mechanisms downstream of caspases for some
forms of AiP are better understood, essential questions about
the regulation of caspases in AiP remain. AiP does not occur
after every cell death. It rather appears to be confined
to stress-induced apoptosis. How is this distinction regulated?
In general, what distinguishes apoptotic from non-apoptotic
functions of caspases? Currently, there are no defini-
tive answers to these and related questions. However, in
the following we review some recent findings on the regu-
lation of Dronc in AiP that give a glimpse at the potential
answers.
Regulating the enzyme: non-degradative mono-ubiquity-
lation regulates Dronc in apoptosis and AiP. It has long
been known that the RING domain of DIAP1 inhibits the
activity of Dronc through ubiquitylation.33–35 However, the
outcome of this ubiquitylation (degradation versus non-
degradative inhibition) was less clear.34,35,79 Recently, we
have identified a novel regulatory mechanism by which
Figure 3 Regulation of caspases in AiP. Caspase activation may lead to apoptotic
cell death or AiP. The exact mechanisms that direct caspase activity toward death or
proliferative functions are not yet clear. When considering what is known regarding
one of the better characterized pathways, the Dronc-dependent AiP in Drosophila
epithelium, there are several possible regulatory mechanisms which could direct
Dronc toward AiP. (a) Direct biochemical modification of caspases: Non-degradative
mono-ubiquitinylation of Dronc inhibits both apoptotic and AiP activity. (b) Direction of
caspases by adaptors or scaffolds: other non-apoptotic functions of Dronc rely on
adaptors to localize the caspase to the non-apoptotic target. It is possible that Dronc-
mediated AiP may be facilitated by an as of yet unidentified adaptor or scaffolding
protein. (c) Feedback loops allow for amplification (green arrows) or inhibition (orange
lines): positive feedback from JNK upregulating the pro-apoptotic factor hid increases
Dronc activity and yields a robust AiP response. Negative feedback from EGFR
signaling can inhibit Hid activity, potentially dampening the AiP response. As new
downstream targets are uncovered for both initiator and effector caspase-dependent
AiP, we will likely develop a better understanding of how a balance among these
varying positive and inhibitory signals drive caspases towards a proliferative function
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ubiquitylation controls the activity of Dronc. Dronc from
embryonic, larval, pupal and adult stages is ubiquitylated
only on one Lysine residue, K78, and this ubiquitylation is a
mono-ubiquitylation which is not a mark for proteasomal
degradation (Figure 3a).36 A ubiquitylation-deficient mutant of
Dronc (DroncK78R) interacts more efficiently with the scaffold-
ing protein Dark and thus induces more apoptosis, suggest-
ing that K78 mono-ubiquitylation of Dronc inhibits the
interaction with Dark which explains at least partially the
inhibitory role of ubiquitylation.36 Removal of K78 mono-
ubiquitin by a deubiquitylase (DUB) may facilitate recruitment
of Dronc into the Dark apoptosome (Figure 3a). While a
specific DUB for this activity is not known, the recently
described DUBA is a good candidate.80
Very surprisingly, a ubiquitylation-deficient and catalytically
dead (due to the change of the catalytic Cys318 to Ala) double
mutant of Dronc (DroncK78RC318A) rescues the strong lethality
of homozygous dronc null mutants which the catalytic-only
mutant DroncC318A was unable to do.36 Because expression of
droncK78RC318A does not rescue the inability of dronc mutants
to induce apoptosis,36,55 these observations suggest that the
non-apoptotic functions of Dronc are more important for the
survival of the fly than its apoptotic one. Moreover, in contrast
to droncC318A, co-expression of droncK78RC318A with p35 does
induce AiP,36 suggesting that mono-ubiquitylation of Dronc
serves also an inhibitory role for the ability of Dronc to induce
AiP (Figure 3a).
This observation also implies that the catalytic activity of
Dronc is not strictly required for AiPandmay offer an answer to
another question that centers on the proteolytic target of Dronc
for AiP. Although Dronc cleaves DrICE and Dcp-1 for induction
of apoptosis, a specific cleavage target of Dronc for AiP has
not been identified although there is evidence that Dronc has
additional cleavage targets.81 The observation that
DroncK78RC318A can induce AiP may suggest that Dronc does
not have a specific cleavage target for AiP. All Dronc needs for
AiP is incorporation into the Dark apoptosome17 which is
facilitated in the absence of K78 ubiquitylation.36 Therefore,
the DroncK78RC318A mutant opens up exciting opportunities for
future investigations not only regarding AiP but also other non-
apoptotic functions of Dronc that are independent of effector
caspase activation.
Regulating the targets: a role for adaptors and scaffolds
directing AiP versus apoptotic death? It is clear that there
is highly specific signaling that leads to AiP, but another
ongoing question is how are caspases directed to their non-
apoptotic targets to promote AiP instead of apoptosis. As
described above, Dronc interacts with the scaffolding protein
Dark/Apaf-1 during the initiation of apoptosis. The apopto-
some provides an environment that facilitates zymogen
activation, and aggregation of caspase activity to cross the
threshold to trigger apoptosis.82,83 When considering other
non-apoptotic functions of Dronc, there are examples of
accessory adaptors interacting with this scaffold to regulate
and direct activity (Figure 3b). For example, in spermatid
differentiation in Drosophila, active Dronc within the apopto-
some is required for cellular remodeling that resolves the
individual spermatids from a larger syncytium.84 Interestingly,
during this non-apoptotic process the active apoptosome
does not induce cell death. The apoptosome is activated and
directed to the proper sub-cellular localization by an adaptor
molecule, Tango7.85,86 Tango7 is required for Dronc to cleave
its targets during this remodeling, with mutant alleles of
Tango7 resulting in male sterility due to a failure of sperm
individualization.85
In contrast, the unconventional myosin Crinkled serves
as an adaptor for caspase substrates during Dronc-dependent
patterning, specifically guiding kinases such a GSK3β
to active Dronc for cleavage and regulation of its activity.87
Both of these interactions were also found in mammals,
with the Tango7 homolog PCID1 interacting with caspase-9,
and the unconventional myosin MYO7A binding to and
regulating a different initiator, caspase-8.86,87 Taken together
these findings in Drosophila and mammals raise the possi-
bility that some as of yet unidentified co-factors could
physically interact with caspases to guide them to AiP
targets preferentially over the cell death effectors, or bring
AiP targets to active caspases while cell execution proceeds
(Figure 3b).
Regulating the response: feedback loops modulate AiP
activity. As detailed above, Dronc triggers AiP through JNK.
While JNK is activated downstream of Dronc, JNK activation
also leads to upregulation of pro-apoptotic hid, amplifying the
initial apoptotic stimulus, caspase activity, and caspase-
driven pathways like AiP (Figure 3c).8,10,17,53,88 In the undead
AiP model, the ROS-recruited hemocytes contribute to this
JNK/Dronc feedback amplification (Figures 2b and 3c).18
Blocking hemocytes in this model not only blocks JNK activity
and AiP but also leads to reduced caspase activity in the
undead cells, a feature not seen when blocking AiP at other
downstream points.18 Adding yet another layer, there is some
evidence that in certain contexts there is JNK-dependent
non-autonomous positive amplification of the apoptotic path-
way in surrounding cells (apoptosis-induced apoptosis),
leading to increased caspase activity, and potentially further
activating a wider AiP response.89,90 Conversely, EGFR
signaling, another player activated downstream of JNK in
AiP,17 negatively regulates Hid activity and reduces caspase-
driven apoptosis in certain cell populations, reducing their
susceptibility to cell death.91–93 This type of feedback could
provide a mechanism to limit caspase-driven AiP preventing
unregulated proliferation.
The AP-1 transcription factors c-Jun and c-Fos are
important for many developmental control programs and,
when specifically phosphorylated by JNK, can activate genes
important for death, survival, cellular remodeling, or prolifera-
tion, depending on the context.57,94,95 In the context of
regenerative proliferation, it was recently demonstrated that
AP-1 can directly bind to a stress-responsive promoter
element of the wg gene which is only activated during
regenerative responses.96 How JNK-activated AP-1 is direc-
ted to this element only under regenerative conditions is
unknown, but other downstream pathways in AiP might
contribute to regulation. For example Atg1, a serine/threonine
kinase known for its role in autophagy, was recently identified
as functioning downstream of JNK to promote AiP indepen-
dently of autophagy.97 Therefore, Atg1 might act as a
modulation factor directing the correct JNK-dependent cellular
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response to stress situations as in AiP. As new downstream
factors like Atg1 are identified and characterized, we should
expect to find more regulatory feedback opportunities fine-
tuning AiP.
The emerging clinical significance of caspase-driven AiP
in cancer
Given that the undead AiP model exploits a sustained
induction of proliferation and results in abnormal, hyperplastic
overgrowth, it has been proposed that this compensatory
mechanism contributes to the aberrant proliferation seen in
cancer.98 Indeed, a number of recent studies have been
exploring the ways in which these physiological regenerative
pathways may be deregulated in human disease and even
hijacked in malignant transformation and growth.
Caspase-dependent tumor repopulation following cyto-
toxic therapies. Increased cell proliferation and rapid
repopulation of tumors following cytotoxic therapy (either
ionizing radiation or chemotherapies) has been a long known
factor in poor treatment response in human cancers, but the
exact mechanism behind this phenomenon had remained
elusive.99,100 Following the description of caspase-3-driven
PGE2 -mediated proliferation in the context of tissue
regeneration (Figure 2e),15 examples of caspase-dependent
PGE2 production directly supporting tumor growth and
repopulation following radiation therapy were found in mouse
models and human cancer cell lines (Figure 4a).40,41 Since
then, possible roles in repopulation for other AiP-associated
factors including caspase-7, PKCδ, Akt, p38, JNK1/2, SHH
and HMGB1 have been identified (Figure 4a).42,43,101,102 A
similar caspase/PGE2 mechanisms of repopulation has also
been found following cytotoxic chemotherapy, confirming this
is not a radiation-specific response.103
AiP, chronic inflammation, and cancer risk. Separate from
their direct role in tumor survival, apoptotic caspases may
also contribute to tumor initiation, caspase-dependent inflam-
mation, and sustained AiP in tumor initiation. Tumors have
been described as analogous to wounds that do not heal,19
and tumor-promoting inflammation is an emerging hallmark of
cancer.104 Chronic inflammatory states, often characterized
by repeated cycles of cell death and incomplete wound
healing, are known to predispose to the development of
certain cancers (Figure 1c).20 Inflammatory bowel diseases
such as ulcerative colitis increase the risk of colorectal carci-
nomas;105 Marjolin’s ulcers, a type of epidermoid carcinoma,
can be found arising from chronically irritated skin or non-
healing scars;106 inflammation of the lungs in severe types of
chronic obstructive pulmonary disease increases the risk of
squamous cell lung cancer, beyond the risk from smoking
exposure alone.107
Figure 4 AiP in cancer and treatment failure. Emerging clinical studies have
found that high levels of activated caspase-3 in tumors is associated with poor
prognosis. Possible mechanisms by which caspase-mediated AiP could be
contributing to tumorigenesis are modeled here. (a) Tumor repopulation following
radiation or chemotherapy: cancer cells sensitive to the cytotoxic treatment initiate
apoptosis and some cells trigger an AiP response through the production of PGE2
and other proliferative cytokines. Overall tumor bulk is initially reduced due to the
apoptotic death, but the remaining cancer cells—including therapy-resistant cells—
are stimulated via AiP to proliferate, repopulating the tumor. Over repeated cycles this
could lead to extremely resistant tumors and eventual treatment failure. (b) Growth
signals from dying tumor cells stimulate angiogenesis: caspase activation in dying
tumor cells has been directly linked to VEGF-A production, a growth factor that
promotes angiogenesis and neovascularization of the tumor. (c) Dying vascular
endothelial cells also trigger AiP: caspase activation in the VE cells results in PGE2
production, which may stimulate further proliferation of the tumor cells
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Just as there are opportunities to connect the dots bet-
ween caspases and mechanisms of regeneration, recent
studies have raised intriguing opportunities to connect AiP
with inflammation-associated tumorigenesis. The initiator
caspase-dependent model of AiP in Drosophila as described
above has demonstrated direct connections between ROS,
macrophage-like immune cells, JNK stress responses, EGF-
mediated signaling, hyperplasia and dysplasia.6–9,16–18,63
In models of human inflammatory pathologies, the connec-
tions are not characterized as rigorously, but conservation of
key players is striking. For example, in a mouse model of
ulcerative colitis in which colonic epithelial cells are exposed to
oxidative stress, JNK signaling and non-apoptotic caspase
activity were linked to each other through mutual feedback, to
cell survival despite DNA damage, to increased proliferation,
and to morphological changes in the epithelium consistent
with early transformation.108 In another example, a chronic-
injury model of liver carcinogenesis in mice showed compen-
satory proliferation and subsequent tumor formation is
mediated by an EGFR-dependent activation of liver macro-
phages following hepatocyte cell death.109 Downregulation of
apoptotic caspases in the parenchyma is sufficient to prevent
the development of these tumors.110
AiP and vasculogenesis in the tumor microenvironment.
Thus far, we have focused on the effects of AiP triggered by
caspase-activated cells of one type acting on neighboring
cells of the same type, with or without an immune
intermediate. However, caspase-dependent AiP can extend
to other cell types in the microenvironment. While cytotoxic
radiotherapy targeting tumor cells can paradoxically drive
AiP-mediated tumor repopulation as described above
(Figure 4a), it can also trigger neovascularization and
angiogenesis via mitogens acting on vascular endo-
thelial (VE) cells. This post-irradiation angiogenesis (PIA) is
thought to contribute to radiotherapy failure in certain
cancers, and new evidence suggests this could be partly
due to a form of caspase-3-dependent AiP acting on VE cells
(Figure 4b).44,111 Blocking caspase-3 in irradiated glioma
cells attenuates new vessel formation, which in turn
suppresses overall tumorigenicity.111 Caspase-3-dependent
production of VEGF-A by these tumor cells appears to
be one of the major factors contributing to PIA, but
several caspase-3-activated signaling pathways may con-
tribute to a pro-angiogenic microenvironment for VE cell
proliferation.44
However, simply blocking angiogenesis is not a panacea.112
VE cells activate caspase-3 following cytotoxic treatments
triggering their own production of the diffusible AiP factor
PGE2, enhancing tumor growth which can lead to therapy
resistance (Figure 4c).113 In addition, independent of formal
angiogenesis, some especially aggressive tumor types can
generate a blood and nutrient supply via a process known as
vasculogenic mimicry (VM).114 VM appears to also involve a
non-apoptotic function of caspases, as caspase-3 activity
contributes to the proliferation of vessel-like channels formed
from highly aggressive cancer cells in certain human
melanomas.38 Very little is known about the precise mechan-
isms of VM, but this may represent more of a caspase-
dependent invasion and metastasis phenotype than true AiP.
Ongoing work in model organisms, is currently investigating
the relationship between caspases, extracellular matrix
remodeling, and metastatic potential.115
Clinical implications for prognosis and improved treat-
ments. Several independent patient cohort studies are now
confirming the clinical relevance of caspase-dependent
repopulation and other non-apoptotic functions of caspases
in these tumors (Figure 4a), finding significant associations
between poor prognosis and elevated caspase-3 expression
and activity. In one study, increased active caspase-3 in
biopsy samples before initiating treatment correlated with
significantly shorter overall survival time in gastric, cervical,
colorectal, and ovarian tumors.116 In another study, elevated
circulating serum levels of caspase activity correlated with
shorter time to progression despite chemotherapy in head
and neck cancers.117 In a third study, activated caspase-3
and increased HMGB1 expression were found in colorectal
cancers and were correlated with poor prognosis, indepen-
dent of their function in metastasis.43
As the details of caspase-dependent AiP and their vital
significance in humans are clarified, the logical next questions
center on employing this knowledge to refine cancer therapy
or even prevent it before it starts. A few experiments have
started to address these questions and have shown promise in
leveraging our understanding of AiP to improve cancer
treatment strategies. For example, knowing that there is
redundancy in AiP signaling, targeting one AiP pathway is
likely not enough, and subsequent cycles of AiP might
expedite and amplify drug-resistance. One study found
modest success in improving colorectal cancer cell killing
in vitro by combining a pro-apoptotic chemotherapeutic with a
cocktail of inhibitors targeting AKT, STAT3 and ERK1/2, three
likely AiP-associated survival and proliferation pathways.118
Two other studies have successfully employed in vivo admin-
istration of celecoxib, an inhibitor of the enzyme
cyclooxygenase-2 (COX2) that synthesizes PGE2 down-
stream of iPLA2, as adjuvant therapy following standard
cytotoxic treatments to prevent tumor progression and
suppress tumor repopulation in a mouse model of melanoma
and a xenograft model of bladder cancer, respectively.103,119
Yet, other questions remain wide open. Are there key
regulatory points in these caspase-dependent pathways that
can be targeted, to distinguish between the various pleiotropic
effects, enhancing the desired anti-tumor functions while
suppressing the undesired pro-tumor functions? What
upstream factors or environmental conditions are driving
cancer cells to have such high caspase levels, even before
the stress of treatment, priming them for a robust AiP
response? Can this knowledge of AiP be harnessed for the
field of regenerative medicine in a way that does not increase
future risk of malignancy?
Conclusion
Caspases are critical not only for apoptotic cell death but
can also stimulate proliferation in response to either death or
non-lethal stresses. Caspase-dependent AiP is not a single
pathway, but an evolutionarily conserved process which
provides mechanisms for healing and adaptation in the face
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of an injurious world. Despite the incredible progress made
over the past decade, there are likely moremechanisms of AiP
that have yet to be uncovered, more upstream regulators
influencing life versus death functions of caspases and more
downstream caspase targets to effect those functions.
Continued work probing AiP in genetically tractable model
organisms will provide clues for which players and pathways
may be at work in human diseases, while clinical investiga-
tions will guide the search for non-apoptotic caspase involve-
ment in new contexts, potentially informing novel therapies
and improving patient outcomes.
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